Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Add-on metoprolol of no benefit to high-risk prostate cancer patients
Use of metoprolol among high-risk prostate cancer patients receiving androgen deprivation therapy does not appear to improve oncological outcomes, as shown in a study.
Add-on metoprolol of no benefit to high-risk prostate cancer patients
29 Sep 2021Palbociclib plus letrozole prolongs survival in Asian patients with advanced breast cancer
Palbociclib plus letrozole as first-line treatment improves progression-free survival (PFS) vs placebo plus letrozole in postmenopausal Asian patients with advanced oestrogen receptor (ER)–positive and HER2-negative breast cancer (BC), primary results of the phase III PALOMA-4 study have shown.
Palbociclib plus letrozole prolongs survival in Asian patients with advanced breast cancer
29 Sep 2021COMS IRIS plaque radiotherapy safe, effective against melanoma
The use of Collaborative Ocular Melanoma Study (COMS) IRIS plaques is an effective treatment approach to iris, iridociliary, and ciliary body melanoma, a recent study has found.
COMS IRIS plaque radiotherapy safe, effective against melanoma
28 Sep 2021Olanzapine a favourable alternative to dexamethasone for CINV
Olanzapine administered at a dose of 5 mg was noninferior to dexamethasone and is associated with fewer adverse effects than dexamethasone for chemotherapy-induced nausea and vomiting (CINV), according to data presented at ESMO 2021.
Olanzapine a favourable alternative to dexamethasone for CINV
27 Sep 2021Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer
A combined regimen of ribociclib plus letrozole as first-line treatment provides a statistically significant and clinically meaningful overall survival (OS) benefit vs placebo plus letrozole in postmenopausal patients with hormone receptor–positive and HER2-negative advanced breast cancer (BC), results of the phase III MONALEESA-2 study have shown.